| | 668270-12-0 Basic information More.. |
| Product Name: | Linagliptin | | Synonyms: | linagliptin;(R)-8-(3-Amino-piperidin-1-yl)-7-but-2-ynyl-3-methyl-1-(4-methyl-quinazolin-2-ylmethyl)-3,7-dihydro-purine-2,6-dione;1H-Purine-2,6-dione, 8-((3R)-3-amino-1-piperidinyl)-7-(2-butynyl)-3,7-dihydro-3-methyl-1-((4-methyl-2-quinazolinyl)methyl)-;Bi 1356;Ondero;8-[(3R)-3-AMino-1-piperidinyl]-7-(2-butyn-1-yl)-3,7-dihydro-3-Methyl-1-[(4-Methyl-2-quinazolinyl)Methyl]-1H-purine-2,6-dione;8-[(3R)-3-AMino-1-piperidinyl]-7-(2-butynyl)-3,7-dihydro-3-Methyl-1-[(4-Methyl-2-quinazolinyl)Methyl]-1H-purine-2,6-d;8-[(3R)-3-aMinopiperidin-1-yl]-7-(but-2-yn-1-yl)-3-Methyl-1-[(4-Methylquinazolin-2-yl)Methyl]-2,3,6,7-tetrahydro-1H-purine-2,6-dione | | CAS: | 668270-12-0 | | MF: | C25H28N8O2 | | MW: | 472.54 | | EINECS: | 1308068-626-2 | | Mol File: | 668270-12-0.mol |  |
Use
Linagliptin is a novel potent and selective dipeptidyl peptidase-4 (DPP-4) inhibitor with potential use in the treatment of type 2 diabetes.
- linagliptin
-
- US $0.00-0.00 / kg
- 2024-09-20
- CAS:668270-12-0
- Min. Order: 1kg
- Purity: 99%，single impurity＜0.1
- Supply Ability: 1 ton
- Linagliptin
-
- US $0.00 / mg
- 2024-09-20
- CAS:668270-12-0
- Min. Order: 10mg
- Purity: 0.98
- Supply Ability: 10g
- Linagliptin
-
- US $0.00 / g
- 2024-09-20
- CAS:668270-12-0
- Min. Order: 1g
- Purity: More Than 99%
- Supply Ability: 100kg/Month
|
|
668270-12-0
Recommend Suppliers |
|